Authors:
FOUNTZILAS G
DIMOPOULOS AM
PAPADIMITRIOU C
KALOGERAFOUNTZILA A
ARAVANTINOS G
BAFALOAKOS D
ATHANASSIADES A
NICOLAIDES C
KERAMOPOULOS A
PAVLIDIS N
KOSMIDIS P
SKARLOS D
Citation: G. Fountzilas et al., FIRST-LINE CHEMOTHERAPY WITH PACLITAXEL BY 3-HOUR INFUSION AND CARBOPLATIN IN ADVANCED BREAST-CANCER (FINAL REPORT) - A PHASE-II STUDY CONDUCTED BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP, Annals of oncology, 9(9), 1998, pp. 1031-1034
Authors:
KOSMIDIS P
SKARLOS D
KOUROUSSIS C
BOUKIS C
BIANCO AR
LELLI G
DELLACUNA GR
SCHULLER J
CALLAGHAN R
OULIDAISSA D
Citation: P. Kosmidis et al., BENEFIT OF GRANOCYTE(R) (LENOGRASTIM) IN PATIENTS TREATED WITH CAMPTO(R) (CPT-11) IN 1ST OR 2ND LINE METASTATIC COLORECTAL-CANCER (MCRC) - PRELIMINARY-RESULTS OF A PHASE-III MULTICENTER TRIAL, Annals of oncology, 9, 1998, pp. 162-162
Authors:
JANINIS J
FOUNTZILAS G
PAPAKOSTAS P
EFSTATHIOU E
VALAGOUTI D
SKARLOS D
Citation: J. Janinis et al., A PHASE-II STUDY OF WEEKLY OXALIPLATIN AND HIGH-DOSE 5-FU WITH LCV AS2ND LINE THERAPY IN PATIENTS WITH ADVANCED COLORECTAL-CANCER, Annals of oncology, 9, 1998, pp. 207-207
Authors:
SAMANTAS E
FOUNTZILAS G
PANOUSSAKI E
BRIASOULIS E
PAVLIDIS N
KALOFONOS G
KARDAMAKIS D
TSIAKOPOULOS E
PALAMIDAS F
SKARLOS D
Citation: E. Samantas et al., RANDOMIZED COMPARISON OF EARLY VS LATE TWICE-DAILY CHEST IRRADIATION CONCURRENTLY WITH CHEMOTHERAPY IN LIMITED DISEASE SMALL-CELL LUNG-CANCER (LD,SCLC), Annals of oncology, 9, 1998, pp. 405-405
Authors:
BAFALOUKOS D
SKARLOS D
FOUNTZILAS G
DIMOPOULOS AM
KOSMIDIS P
Citation: D. Bafaloukos et al., PACLITAXEL IN COMBINATION WITH DOXORUBICIN IN ADVANCED ADULT SOFT-TISSUE SARCOMA (ASTS) - A HELLENIC COOPERATIVE PHASE-II STUDY, Annals of oncology, 9, 1998, pp. 575-575
Authors:
SAMANTAS E
KIAMOURIS C
KALOFONOS H
KOUROUSIS H
ARAVANTINOS G
JANINIS J
ANDROULAKIS N
KOURMPANIS V
FOUNTZILAS G
SKARLOS D
Citation: E. Samantas et al., PHASE-II STUDY WITH DOCETAXEL IN PRETREATED PATIENTS WITH SMALL-CELL LUNG-CANCER, Annals of oncology, 9, 1998, pp. 396-396
Authors:
FOUNTZILAS G
DIMOPOULOS M
PAPADIMITRIOU C
ARAVANTINOS G
BRIASSOULIS E
BAFALOUKOS D
PAPAKOSTAS P
PAVLIDIS N
SKARLOS D
Citation: G. Fountzilas et al., DOSE-DENSE SEQUENTIAL ADJUVANT CHEMOTHERAPY WITH EPIRUBICIN, PACLITAXEL AND CMF IN PATIENTS WITH OPERABLE BREAST-CANCER AND GREATER-THAN-OR-EQUAL-TO-10 POSITIVE AXILLARY NODES, Annals of oncology, 9, 1998, pp. 685-685
Authors:
JANINIS J
EFSTATHIOU E
ARAVANTINOS G
SAMANTAS E
TSELEPIDAKIS K
DERVENIS E
SKARLOS D
Citation: J. Janinis et al., PHASE-II STUDY OF OXALIPLATIN COMBINED WITH 5-DAY INFUSION OF 5-FU AND LCV IN ADVANCED COLORECTAL-CANCER PRELIMINARY DATA, Annals of oncology, 9, 1998, pp. 686-686
Authors:
NICOLAIDES C
GIANNAKAKIS T
SKARLOS D
ATHANASSIADIS A
FOUNTZILAS G
DAMIGOS D
PAVLIDIS N
Citation: C. Nicolaides et al., TROPISETRON IN THE PREVENTION OF ACUTE NAUSEA AND VOMITING IN PATIENTS TREATED WITH HIGH-DOSE EPIRUBICIN, Journal of experimental & clinical cancer research, 17(1), 1998, pp. 71-75
Authors:
SIVOLAPENKO GB
SKARLOS D
PECTASIDES D
STATHOPOULOU E
MILONAKIS A
SIRMALIS G
STUTTLE A
COURTENAYLUCK NS
KONSTANTINIDES K
EPENETOS AA
Citation: Gb. Sivolapenko et al., IMAGING OF METASTATIC MELANOMA UTILIZING A TC-99M LABELED RGD-CONTAINING SYNTHETIC PEPTIDE, European journal of nuclear medicine, 25(10), 1998, pp. 1383-1389
Authors:
BRIASOULIS E
TSOKOS M
FOUNTZILAS G
BAFALOUKOS D
KOSMIDIS P
SAMANTAS E
SKARLOS D
NICOLAIDES C
PAVLIDIS N
Citation: E. Briasoulis et al., BCL2 AND P53 PROTEIN EXPRESSION IN METASTATIC CARCINOMA OF UNKNOWN PRIMARY ORIGIN - BIOLOGICAL AND CLINICAL IMPLICATIONS - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, Anticancer research, 18(3B), 1998, pp. 1907-1914
Authors:
KALOGERAFOUNTZILA A
KOSMIDIS P
BACOYIANNIS C
NICOLAOU A
SAMANTAS E
BRIASSOULIS E
PAVLIDIS N
SKARLOS D
DANILIDIS J
FOUNTZILAS G
Citation: A. Kalogerafountzila et al., PROGNOSTIC FACTORS INFLUENCING COMPLETE RESPONSE TO TREATMENT AND SURVIVAL OF PATIENTS WITH NASOPHARYNGEAL CANCER, Anticancer research, 18(1B), 1998, pp. 587-593
Authors:
FOUNTZILAS GG
NICOLAIDES C
ARAVANTINOS G
SKARLOS D
KOSMIDIS P
PAPAKOSTAS P
STATHOPOULOS GP
KONTOSTOLIS E
BAFALOUKOS D
PAVLIDIS N
Citation: Gg. Fountzilas et al., DOSE-DENSE ADJUVANT CHEMOTHERAPY WITH EPIRUBICIN MONOTHERAPY IN PATIENTS WITH OPERABLE BREAST-CANCER AND GREATER-THAN-OR-EQUAL-TO-10 POSITIVE AXILLARY LYMPH-NODES - A FEASIBILITY STUDY, Oncology, 55(6), 1998, pp. 508-512
Authors:
NICOLAIDES C
FOUNTZILAS G
ZOUMBOS N
SKARLOS D
KOSMIDIS P
PECTASIDES D
KARABELIS A
GIANNAKAKIS T
SYMEONIDIS A
PAPADOPOULOS A
ANTONIOU F
PAVLIDIS N
Citation: C. Nicolaides et al., DIFFUSE LARGE-CELL LYMPHOMAS - IDENTIFICATION OF PROGNOSTIC FACTORS AND VALIDATION OF THE INTERNATIONAL NON-HODGKINS-LYMPHOMA PROGNOSTIC INDEX - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, Oncology, 55(5), 1998, pp. 405-415
Authors:
BAFALOUKOS D
FOUNTZILAS G
SKARLOS D
PAVLIDIS N
BAKOYIANNIS C
KARVOUNIS N
KOSMIDIS P
Citation: D. Bafaloukos et al., SUBCUTANEOUS LOW-DOSES OF INTERLEUKIN-2 AND RECOMBINANT INTERFERON-ALPHA WITH CARBOPLATIN AND VINBLASTINE IN PATIENTS WITH ADVANCED MELANOMA, Oncology, 55(1), 1998, pp. 48-52
Authors:
BACOYIANNIS C
DIMOPOULOS MA
NICOLAIDES C
ARAVANTINOS G
XIROS N
SKARLOS D
PAVLIDIS N
KOSMIDIS P
Citation: C. Bacoyiannis et al., PHASE-II STUDY OF INTERFERON-GAMMA (RIFN-G) AND VINBLASTINE (VBL) IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA (RCC), European journal of cancer, 33, 1997, pp. 177-177
Authors:
KOSMIDIS P
BAFALOUKOS D
SKARLOS D
PAVLIDIS N
ARAVANTINOS G
ATHANASIADIS A
KARPATHIOS S
FOUNTZILAS G
Citation: P. Kosmidis et al., INTRAPERITONEAL (IP) INTERFERON A2B (INF) CONSOLIDATION IN CCR OVARIAN-CANCER (OC) PATIENTS FOLLOWING CARBOPLATIN CHEMOTHERAPY (CT), European journal of cancer, 33, 1997, pp. 385-385
Authors:
BAFALOUKOS D
ARAVANTINOS G
SKARLOS D
KATSIFIS G
BACOYIANNIS C
KOSMIDIS P
Citation: D. Bafaloukos et al., PHASE-II STUDY OF CARBOPLATIN BASED CHEMOTHERAPY IN COMBINATION WITH MEDROXYPROGESTERONE ACETATE (MPA) IN ADVANCED ENDOMETRIAL CANCER, European journal of cancer, 33, 1997, pp. 953-953
Authors:
FOUNTZILAS G
ATHANASSIADIS A
KALOGERAFOUNTZILA A
ARAVANTINOS G
BAFALOUKOS D
BRIASOULIS E
DOMBROS N
IOANNIDIS I
PAVLIDIS N
KOSMIDIS P
SKARLOS D
Citation: G. Fountzilas et al., PACLITAXEL BY 3-H INFUSION AND CARBOPLATIN IN ANTHRACYCLINE-RESISTANTADVANCED BREAST-CANCER - A PHASE-II STUDY CONDUCTED BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP, European journal of cancer, 33(11), 1997, pp. 1893-1895
Authors:
KOSMIDIS PA
MYLONAKIS N
FOUNTZILAS G
SAMANTAS E
ATHANASIADIS A
ANDREOPOULOU E
PAVLIDIS N
SKARLOS D
Citation: Pa. Kosmidis et al., PACLITAXEL AND CARBOPLATIN IN INOPERABLE NON-SMALL-CELL LUNG-CANCER -A PHASE-II STUDY, Annals of oncology, 8(7), 1997, pp. 697-699
Authors:
FOUNTZILAS G
SKARLOS D
ATHANASSIADES A
KALOGERAFOUNTZILA A
SAMANTAS E
BACOYIANNIS C
NICOLAOU A
DOMBROS N
BRIASOULIS E
DINOPOULOU M
STATHOPOULOS G
PAVLIDIS N
KOSMIDIS P
DANIILIDIS J
Citation: G. Fountzilas et al., PACLITAXEL BY 3-HOUR INFUSION AND CARBOPLATIN IN ADVANCED-CARCINOMA OF NASOPHARYNX AND OTHER SITES OF THE HEAD AND NECK - A PHASE-II STUDY CONDUCTED BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP, Annals of oncology, 8(5), 1997, pp. 451-455
Authors:
KOSMIDIS PA
BACOYIANNIS C
FOUNTZILAS G
ARAVANTINOS G
TSAVARIS N
MILATHIANAKIS C
SKARLOS D
Citation: Pa. Kosmidis et al., 5-FLUOROURACIL, INTERFERON-ALPHA-2B AND CISPLATIN (FAP) FOR ADVANCED UROTHELIAL CANCER - A PHASE-II STUDY, Annals of oncology, 8(4), 1997, pp. 373-378
Authors:
FOUNTZILAS G
ATHANASSIADES A
GIANNAKAKIS T
BRIASOULIS E
BAFALOUKOS D
KALOGERAFOUNTZILA A
ONIENAOUM A
KALOFONOS H
PECTASIDES D
ANDREOPOULOU E
BAMIA C
KOSMIDIS P
PAVLIDIS N
SKARLOS D
Citation: G. Fountzilas et al., A RANDOMIZED STUDY OF EPIRUBICIN MONOTHERAPY EVERY 4 OR EVERY 2 WEEKSIN ADVANCED BREAST-CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, Annals of oncology, 8(12), 1997, pp. 1213-1220
Authors:
NICOLAIDES C
KLOUVAS G
FOUNTZILAS G
ATHANASSIADIS A
SKARLOS D
SAMANTAS E
KOSMIDIS P
MYLONAKIS N
PAVLIDIS N
Citation: C. Nicolaides et al., INTENSIFIED CARBOPLATIN REGIMEN WITH GM-CSF SUPPORT IN NONSMALL CELL LUNG-CANCER (NSCLC) - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY (HECOG), Journal of experimental & clinical cancer research, 16(1), 1997, pp. 91-94